Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty?

(E-pub Ahead of Print)

Author(s): Hanan Hamed Soliman, Mohamed H. Emara, Mahmoud Elkadeem, Sherief Abd-Elsalam*

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders


Article ID: e160921189886
Become EABM
Become Reviewer
Call for Editor

Abstract:

In the late 2019, coronavirus-2 (SARS-COV 2) infection emerged in Wuhan, China and spread to all countries making the first pandemic in 21st century. It seems that this infection will continue period which is long enough to obligate modifications in both life style and health care systems. Because chronic liver diseases (CLD) are prevalent all over the world, it is expected to manage patients with CLD and COVID-19. The aim of this review was to shade the light on the impact of COVID-19 pandemic on the management of patients with CLD and how to give medical care to CLD patients during COVID-19 pandemic.

Keywords: Coronavirus disease, COVID-19, pandemic, chronic liver diseases, cirrhosis, HCC.

Rights & PermissionsPrintExport Cite as

Article Details

Article ID: e160921189886
(E-pub Ahead of Print)
DOI: 10.2174/1871526520666210104152256
Price: $95

Article Metrics

PDF: 435